BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grosso G, Mistretta A, Marventano S, Ferranti R, Mauro L, Cunsolo R, Proietti L, Malaguarnera M. Long-term persistence of seroprotection by hepatitis B vaccination in healthcare workers of southern Italy. Hepat Mon. 2012;12:e6025. [PMID: 23087756 DOI: 10.5812/hepatmon.6025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Rapisarda V, Loreto C, Malaguarnera M, Ardiri A, Proiti M, Rigano G, Frazzetto E, Ruggeri MI, Malaguarnera G, Bertino N, Malaguarnera M, Catania VE, Di Carlo I, Toro A, Bertino E, Mangano D, Bertino G. Hepatocellular carcinoma and the risk of occupational exposure. World J Hepatol 2016; 8(13): 573-590 [PMID: 27168870 DOI: 10.4254/wjh.v8.i13.573] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
2 Corrao CR, Del Cimmuto A, Marzuillo C, Paparo E, La Torre G. Association between waste management and HBV among solid municipal waste workers: a systematic review and meta-analysis of observational studies. ScientificWorldJournal 2013;2013:692083. [PMID: 24228011 DOI: 10.1155/2013/692083] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
3 Al Ghamdi SS, Fallatah HI, Fetyani DM, Al-Mughales JA, Gelaidan AT. Long-term efficacy of the hepatitis B vaccine in a high-risk group. J Med Virol 2013;85:1518-22. [PMID: 23852676 DOI: 10.1002/jmv.23658] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
4 Dumaidi K, Al-Jawabreh A. Persistence of Anti-HBs Among Palestinian Medical Students After 18 - 22 Years of Vaccination: A Cross-Sectional Study. Hepat Mon 2015;15:e29325. [PMID: 26834785 DOI: 10.5812/hepatmon.29325] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
5 van Leeuwen LPM, Doornekamp L, Goeijenbier S, de Jong W, de Jager HJ, van Gorp ECM, Goeijenbier M. Evaluation of the Hepatitis B Vaccination Programme in Medical Students in a Dutch University Hospital. Vaccines (Basel) 2021;9:69. [PMID: 33498258 DOI: 10.3390/vaccines9020069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Meidani M, Khorvash F, Hemati S, Ashrafi F, Ataei B, Daneshmand D. The Immune Response of Vaccination Against Hepatitis B virus in Iranian Patients Undergoing Chemotherapy. Adv Biomed Res 2017;6:88. [PMID: 28828339 DOI: 10.4103/abr.abr_330_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Pourkarim MR, Amini-Bavil-Olyaee S, Kurbanov F, Van Ranst M, Tacke F. Molecular identification of hepatitis B virus genotypes/subgenotypes: Revised classification hurdles and updated resolutions. World J Gastroenterol 2014; 20(23): 7152-7168 [PMID: 24966586 DOI: 10.3748/wjg.v20.i23.7152] [Cited by in CrossRef: 102] [Cited by in F6Publishing: 96] [Article Influence: 12.8] [Reference Citation Analysis]
8 Azarkar Z, Ebrahimzadeh A, Sharifzadeh G, Ziaee M, Fereidouni M, Taheri F. Persistence of immunity to hepatitis B vaccine as infants, 17 years earlier. Caspian J Intern Med 2018;9:184-8. [PMID: 29732038 DOI: 10.22088/cjim.9.2.184] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Lai A, Sagnelli C, Presti AL, Cella E, Angeletti S, Spoto S, Costantino S, Sagnelli E, Ciccozzi M. What is changed in HBV molecular epidemiology in Italy? J Med Virol. 2018;90:786-795. [PMID: 29315661 DOI: 10.1002/jmv.25027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
10 Sagnelli C, Sagnelli E. Towards the worldwide eradication of hepatitis B virus infection: A combination of prophylactic and therapeutic factors. World J Clin Infect Dis 2019; 9(2): 11-22 [DOI: 10.5495/wjcid.v9.i2.11] [Cited by in CrossRef: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Hustache S, Moyroud L, Goirand L, Epaulard O. Hepatitis B vaccination status in an at-risk adult population: long-term immunity but insufficient coverage. Eur J Clin Microbiol Infect Dis 2017;36:1483-9. [PMID: 28285330 DOI: 10.1007/s10096-017-2957-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bolther M, Andersen KLD, Tolstrup M, Visvanathan K, Woolley I, Skinner N, Millen R, Warner N, Østergaard L, Jensen-Fangel S. Levels of regulatory B cells do not predict serological responses to hepatitis B vaccine. Hum Vaccin Immunother 2018;14:1483-8. [PMID: 29474139 DOI: 10.1080/21645515.2018.1441653] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]